Garlatti Costa, E.; Bitetto, D.; Fornasiere, E.; Fumolo, E.; Ferrarese, A.; Toniutto, P.
Efficacy and Safety of GLP-1 Receptor Agonists and SGLT-2 Inhibitors in the Treatment of Diabetes Mellitus and Obesity in Liver Transplant Recipients: A Systematic Review. J. Clin. Med. 2025, 14, 4619.
https://doi.org/10.3390/jcm14134619
AMA Style
Garlatti Costa E, Bitetto D, Fornasiere E, Fumolo E, Ferrarese A, Toniutto P.
Efficacy and Safety of GLP-1 Receptor Agonists and SGLT-2 Inhibitors in the Treatment of Diabetes Mellitus and Obesity in Liver Transplant Recipients: A Systematic Review. Journal of Clinical Medicine. 2025; 14(13):4619.
https://doi.org/10.3390/jcm14134619
Chicago/Turabian Style
Garlatti Costa, Elena, Davide Bitetto, Ezio Fornasiere, Elisa Fumolo, Alberto Ferrarese, and Pierluigi Toniutto.
2025. "Efficacy and Safety of GLP-1 Receptor Agonists and SGLT-2 Inhibitors in the Treatment of Diabetes Mellitus and Obesity in Liver Transplant Recipients: A Systematic Review" Journal of Clinical Medicine 14, no. 13: 4619.
https://doi.org/10.3390/jcm14134619
APA Style
Garlatti Costa, E., Bitetto, D., Fornasiere, E., Fumolo, E., Ferrarese, A., & Toniutto, P.
(2025). Efficacy and Safety of GLP-1 Receptor Agonists and SGLT-2 Inhibitors in the Treatment of Diabetes Mellitus and Obesity in Liver Transplant Recipients: A Systematic Review. Journal of Clinical Medicine, 14(13), 4619.
https://doi.org/10.3390/jcm14134619
